Replies to post #4275 on Rebus Holdings Inc (RBSH)

[Floppyplants]

LMAO

[HighPeaks]

There is compelling evidence that suggests that JLL is involved.
The address in last weeks filing was not Conor Flannery’s personal address but that of JLL. It’s possible(although I can’t say conclusively) that JLL is somewhat involved in Inspyr Therapeutics,perhaps even taking a controlling interest in the company.
Here is the address in the filing:



That is the address for JLL:

[Rigamortis Raccoon]

I don't think NSPX is contracted directly with JLL per se, which yes, contradicts what I posted earlier, but that's not to say they won't be contacting with a 3rd party manufacturer if NSPX is able to go to market with a drug through a GMP facility or R&D facility.

OR, JLL as a company has no involvement, it could just be this one employee. I do not know him personally, but know people he works with. I think the last thing JLL would want from one of their employees being a shareholder is an eventual conflict of interest.

Everything IMHO. To an extent I believe you're correct.